| (Values in U.S. Thousands) | Sep, 2025 | Mar, 2025 | Sep, 2024 | Mar, 2024 | Sep, 2023 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Oxford Instruments Plc (OXIG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Oxford Instruments PLC is engaged in researching, developing, manufacturing, renting, selling, and servicing high-technology tools and systems. The company's operating segment includes Materials and Characterisation; Research and Discovery and Service and Healthcare. It generates maximum revenue from the Materials and Characterisation segment. The Materials and Characterisation segment focuses on applied R&D and commercial customers, enabling the fabrication and characterization of materials and devices down to the atomic scale. Geographically, it derives a majority of its revenue from Asia and also has a presence in Europe, North America, and the Rest of the World.
Fiscal Year End Date: 03/31